Sign In
Buy ALPMF
$13.25
-0.473 (-3.44%)
At Close: Jun 03, 2026
Astellas Pharma Inc. (ALPMF) Q2 2023 Earnings Call Transcript
10:42pm, Sunday, 06'th Aug 2023
Astellas Pharma Inc. (OTCPK:ALPMF) Q2 2023 Earnings Conference Call August 1, 2023 4:00 AM ET Company Participants Hiromitsu Ikeda - Corporate Head, Advocacy and Relations Naoki Okamura - Representati
Astellas Completes Acquisition of Iveric Bio
07:00pm, Tuesday, 11'th Jul 2023
TOKYO and PARSIPPANY, N.J. , July 11, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has successfully completed the acquisi
You can't rely on indexes to pick international stocks, this 5-star fund manager says. Here are 3 of his top selections.
10:04am, Monday, 22'nd May 2023
You have probably seen coverage of a renewed interest in Japanese stocks among well-known investors, including Berkshire Hathaway BRK.B, -0.57% CEO Warren Buffett. But Krishna Mohanraj, who runs a hig
Astellas Pharma CEO Says Confident of Iveric Bio Drug Approval
08:58pm, Monday, 01'st May 2023
Naoki Okamura, chief executive officer of Japanese drugmaker Astellas Pharma Inc., discusses his company's decision to acquire Iveric Bio Inc., a developer of drugs to treat age-related blindness, f
Iveric Bio stock surges on Astellas Pharma takeover deal
03:13pm, Monday, 01'st May 2023
Iveric Bio Inc shares climbed 16% to $38.01 on Monday after the US drugmaker agreed to be acquired by Japan's Astellas Pharma for $40 per share in cash or total consideration of about $5.9 billion.
Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas Pharma
10:01am, Monday, 01'st May 2023
Astellas Pharma snapped up Iveric Bio for $5.9 billion in cash, the companies said Monday in an announcement that sent ISEE stock flying. The post Biotech Buying Bonanza: Iveric Bio Snags $5.9 Billion
Japan's Astellas Pharma to buy Iveric Bio in deal worth $5.9 billion
01:34am, Monday, 01'st May 2023
Astellas Pharma Inc. said Monday that it agreed to acquire Iveric bio Inc. for about $5.9 billion to strengthen its capabilities in the ophthalmology field.
Astellas Pharma Inc. (ALPMF) Q4 2022 Earnings Call Transcript
11:32am, Saturday, 29'th Apr 2023
Astellas Pharma Inc. (OTCPK:ALPMF) Q4 2022 Results Conference Call April 27, 2023 3:00 AM ET Company Participants Hiromitsu Ikeda - Corporate Head, Advocacy and Relations Naoki Okamura - Representativ
Astellas Pharma Inc. (ALPMF) Q3 2022 Earnings Call Transcript
01:52pm, Monday, 06'th Feb 2023
Astellas Pharma Inc. (OTCPK:ALPMF) Q3 2022 Earnings Conference Call February 6, 2023 1:30 AM ET Company Participants Hiromitsu Ikeda - Corporate Head, Advocacy and Relations Kenji Yasukawa - President
Astellas Pharma's (ALPMF) Management on Q1 2021 Results - Earnings Call Transcript
08:18pm, Tuesday, 04'th Aug 2020
Astellas Pharma Inc (OTCPK:ALPMF) Q1 2021 Earnings Conference Call August 04, 2020 3:00 AM ET Company Participants Naoki Okamura – Representative Director and Executive Vice President Mike Kitagawa
